Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition

Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition

Aug 25, 2022 | Interviews

Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition Alex Brill, a senior fellow at the American Enterprise Institute and CEO of Matrix Global Advisors, recently sat down with CAPD spokesperson Maura Keefe to...
New PCMA Podcast Highlights Importance of Prescription Drug Rebates

New PCMA Podcast Highlights Importance of Prescription Drug Rebates

Aug 16, 2022 | Press Releases

New PCMA Podcast Highlights Importance of Prescription Drug Rebates PCMA released the following press release regarding Alex Brill’s interview on the importance of prescription drug rebates. (Washington, D.C.) — The Pharmaceutical Care Management Association’s...
MGA Report Cited in Forbes Article on Rising Prescription Drug Prices

MGA Report Cited in Forbes Article on Rising Prescription Drug Prices

Mar 21, 2022 | News

MGA Report Cited in Forbes Article on Rising Prescription Drug Prices In his Forbes article, Ike Brannon discusses the blame game being played in Washington in regards to skyrocketing drug prices. In particular, he argues against what he sees as unnecessary blame...
New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition

New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition

Mar 1, 2022 | Analysis

New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition MGA has released a new report today, “Understanding Drug Rebates and Their Role in Promoting Competition,” authored by founder and CEO Alex Brill. Offering new analysis on the...
  • Analysis (37)
  • Books (3)
  • Events (15)
  • Interviews (46)
  • News (51)
  • Op-Eds (79)
  • Press Releases (3)
  • Testimony (20)
  • Humira rivals drive down cost
    Humira Rivals Set to Try to Drive Down Cost of Blockbuster DrugJanuary 31, 2023
  • patent thickets lost drug savings
    New Report from MGA Examines the One-Year Cost Savings Lost Due to Patent ThicketsJanuary 26, 2023
  • Biosimilar Coverage in Commercial
    New MGA Analysis of Biosimilar Coverage in Commercial Medical BenefitDecember 8, 2022
  • Narrow House GOP Victory
    Narrow House GOP Victory Should Point Toward Policy Development AgendaDecember 6, 2022
  • Pandemic Fatigue Inhibit Pandemic Preparedness
    Don’t Let Pandemic Fatigue Inhibit Pandemic PreparednessNovember 15, 2022
  • Pro-Growth Tax System.
    American Renewal: A Simpler, More Responsible, and Pro-Growth Tax SystemNovember 15, 2022
  • Macroeconomics of the Child Tax Credit
    Macroeconomics of the Child Tax CreditNovember 10, 2022
  • 2022 Midterms and federal taxes
    2022 Midterms: How a Democratic or GOP Congress May Impact Your Federal TaxesOctober 26, 2022
  • Importance of Prescription Drug Rebates
    ‘The Price of Business’: Discussing State Taxation of Student Loan ForgivenessOctober 12, 2022
  • Massachusetts Millionaire’s Tax
    More Concerns with the Massachusetts Millionaire’s TaxOctober 11, 2022
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact